Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) shares hit a new 52-week high on Tuesday . The company traded as high as $9.41 and last traded at $9.41, with a volume of 192 shares trading hands. The stock had previously closed at $8.71.
Aspen Pharmacare Stock Performance
The company has a quick ratio of 2.66, a current ratio of 3.64 and a debt-to-equity ratio of 0.36. The stock has a 50 day moving average price of $8.66 and a 200-day moving average price of $7.80.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Further Reading
- Five stocks we like better than Aspen Pharmacare
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
